Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
Makhlin I, McAndrew NP, Wileyto EP, Clark AS, Holmes R, Bottalico LN, Mesaros C, Blair IA, Jeschke GR, Fox KR, Domchek SM, Matro JM, Bradbury AR, Feldman MD, Hexner EO, Bromberg JF, DeMichele A. Makhlin I, et al. Among authors: clark as. NPJ Breast Cancer. 2022 Nov 11;8(1):122. doi: 10.1038/s41523-022-00487-x. NPJ Breast Cancer. 2022. PMID: 36369506 Free PMC article.
Clinical management of hereditary breast cancer syndromes.
Clark AS, Domchek SM. Clark AS, et al. J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):17-25. doi: 10.1007/s10911-011-9200-x. Epub 2011 Mar 1. J Mammary Gland Biol Neoplasia. 2011. PMID: 21360002 Review.
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.
DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, Lal P, Feldman M, Zhang P, Colameco C, Lewis D, Langer M, Goodman N, Domchek S, Gogineni K, Rosen M, Fox K, O'Dwyer P. DeMichele A, et al. Among authors: clark as. Clin Cancer Res. 2015 Mar 1;21(5):995-1001. doi: 10.1158/1078-0432.CCR-14-2258. Epub 2014 Dec 11. Clin Cancer Res. 2015. PMID: 25501126 Clinical Trial.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
DeMichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY, Clark A, Edmiston K, Elias AD, Forero-Torres A, Haddad TC, Haley B, Haluska P, Hylton NM, Isaacs C, Kaplan H, Korde L, Leyland-Jones B, Liu MC, Melisko M, Minton SE, Moulder SL, Nanda R, Olopade OI, Paoloni M, Park JW, Parker BA, Perlmutter J, Petricoin EF, Rugo H, Symmans F, Tripathy D, van't Veer LJ, Viscusi RK, Wallace A, Wolf D, Yau C, Esserman LJ. DeMichele A, et al. Clin Cancer Res. 2015 Jul 1;21(13):2911-5. doi: 10.1158/1078-0432.CCR-14-1760. Epub 2015 Feb 24. Clin Cancer Res. 2015. PMID: 25712686 Free PMC article.
HER2 imaging in the ZEPHIR study.
Clark AS, DeMichele A, Mankoff D. Clark AS, et al. Ann Oncol. 2016 Apr;27(4):555-7. doi: 10.1093/annonc/mdw033. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802154 Free article. No abstract available.
Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
Narayan HK, French B, Khan AM, Plappert T, Hyman D, Bajulaiye A, Domchek S, DeMichele A, Clark A, Matro J, Bradbury A, Fox K, Carver JR, Ky B. Narayan HK, et al. JACC Cardiovasc Imaging. 2016 Oct;9(10):1131-1141. doi: 10.1016/j.jcmg.2015.11.024. Epub 2016 Apr 13. JACC Cardiovasc Imaging. 2016. PMID: 27085442 Free PMC article.
Immunotherapy for Breast Cancer: What Are We Missing?
Vonderheide RH, Domchek SM, Clark AS. Vonderheide RH, et al. Among authors: clark as. Clin Cancer Res. 2017 Jun 1;23(11):2640-2646. doi: 10.1158/1078-0432.CCR-16-2569. Clin Cancer Res. 2017. PMID: 28572258 Free PMC article.
208 results